Inventor
CHEUNG MUI
US44 patents
⚠️ This page may combine multiple inventors who share the name “CHEUNG MUI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SMITHKLINE BEECHAM CORP
14 patentsUS7105530B2Sep 12, 2006
Pyrimidineamines as angiogenesis modulators
SMITHKLINE BEECHAM CORP72 citations96
US7595330B2Sep 29, 2009
Benzimidazole thiophene compounds
SMITHKLINE BEECHAM CORP20 citations91
US7262203B2Aug 28, 2007
Pyrimidineamines as angiogenesis modulators
SMITHKLINE BEECHAM CORP32 citations90
US7238813B2Jul 3, 2007
Chemical compounds
SMITHKLINE BEECHAM CORP20 citations81
US7189712B2Mar 13, 2007
1,3-Oxazole compounds for the treatment of cancer
SMITHKLINE BEECHAM CORP13 citations81
US7338959B2Mar 4, 2008
Diamino-pyrimidines and their use as angiogenesis inhibitors
SMITHKLINE BEECHAM CORP16 citations79
US7141569B2Nov 28, 2006
Antiviral pyrazolopyridine compounds
SMITHKLINE BEECHAM CORP9 citations73
US7109209B2Sep 19, 2006
Pyrazolopyridines, process for their preparation and use as therapeutic compounds
SMITHKLINE BEECHAM CORP8 citations72
US7034030B2Apr 25, 2006
Pyralopyridines, process for their preparation and use as therapeutic compounds
SMITHKLINE BEECHAM CORP6 citations72
US7615643B2Nov 10, 2009
Benzimidazole thiophene compounds
SMITHKLINE BEECHAM CORP6 citations55
US7459455B2Dec 2, 2008
Pyrimidine compounds
SMITHKLINE BEECHAM CORP1 citations48
US7163940B2Jan 16, 2007
Pyrazolopyridinyl pyrimidine therapeutic compounds
SMITHKLINE BEECHAM CORP1 citations47
US7465807B2Dec 16, 2008
Process for preparing benzimidazole thiophenes
SMITHKLINE BEECHAM CORP0 citations39
US7462614B2Dec 9, 2008
Imidazotriazine compounds
SMITHKLINE BEECHAM CORP0 citations36
GLAXOSMITHKLINE IP DEV LTD
8 patentsUS9035063B2May 19, 2015
Compounds as rearranged during transfection (RET) inhibitors
GLAXOSMITHKLINE IP DEV LTD55 citations97
US8937071B2Jan 20, 2015
Compounds as rearranged during transfection (RET) inhibitors
GLAXOSMITHKLINE IP DEV LTD59 citations95
US11312709B2Apr 26, 2022
Ghrelin O-acyltransferase inhibitors
GLAXOSMITHKLINE IP DEV LTD0 citations61
US11547704B2Jan 10, 2023
Chemical compounds
GLAXOSMITHKLINE IP DEV LTD1 citations60
US10851053B2Dec 1, 2020
Chemical compounds
GLAXOSMITHKLINE IP DEV LTD1 citations59
US10294236B2May 21, 2019
Compounds as rearranged during transfection (RET) inhibitors
GLAXOSMITHKLINE IP DEV LTD0 citations50
US9879021B2Jan 30, 2018
Compounds as rearranged during transfection (RET) inhibitors
GLAXOSMITHKLINE IP DEV LTD1 citations50
US11773078B2Oct 3, 2023
Furin inhibitors
GLAXOSMITHKLINE IP DEV LTD0 citations48
GLAXOSMITHKLINE LLC
8 patentsUS10174049B2Jan 8, 2019
Compounds as diacylglycerol acyltransferase inhibitors
GLAXOSMITHKLINE LLC1 citations71
US9879031B2Jan 30, 2018
Compounds as diacylglycerol acyltransferase inhibitors
GLAXOSMITHKLINE LLC1 citations61
US9796729B2Oct 24, 2017
Compounds as diacylglycerol acyltransferase inhibitors
GLAXOSMITHKLINE LLC1 citations61
US9738658B2Aug 22, 2017
Compounds as diacylglycerol acyltransferase inhibitors
GLAXOSMITHKLINE LLC1 citations61
US9221766B2Dec 29, 2015
Compounds as diacylglycerol acyltransferase inhibitors
GLAXOSMITHKLINE LLC3 citations61
US7858626B2Dec 28, 2010
Pyrimidineamines as angiogenesis modulators
GLAXOSMITHKLINE LLC3 citations58
US10385066B2Aug 20, 2019
Compounds as diacylglycerol acyltransferase inhibitors
GLAXOSMITHKLINE LLC0 citations51
US9624174B2Apr 18, 2017
Compounds as diacylglycerol acyltransferase inhibitors
GLAXOSMITHKLINE LLC0 citations50